AAO News
The latest clinical breakthroughs, practice management updates, and national advocacy alerts directly from the American Academy of Ophthalmology.
Once-daily glaucoma drop shows promise
Aerie Pharmaceuticals announced positive 12-month interim safety results for Rhopressa, a once-daily eye drop for patients with glaucoma or ocular hypertension.
Powered by Steuernachrichten

West Virginia Academy of Eye Physicians and Surgeons — advancing quality eye care through education, advocacy, and community awareness.
About
Resources
Advocacy

























